Stryker Corp. closed 14.23% below its 52-week high of $406.19, which the company achieved on January 28th.

Stryker is a global player in the medical device industry, with over $20 billion in revenue and a presence in 75 countries.

Using military hardware typically reserved for missions overseas, the Trump administration looks to send a message that the ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...

Truist analyst Richard Newitter lowered the firm’s price target on Stryker (SYK) to $390 from $413 and keeps a Hold rating on the shares as ...

New US tariffs could disrupt the medtech industry, impacting major companies like Boston Scientific and Stryker. Read more ...

We recently published a list of the 10 Best Robotics Stocks to Buy According to Billionaires. In this article, we are going ...

Stryker will host a webcast at 4:30 p.m. ET on Thursday, May 1, 2025, to discuss its first quarter 2025 results. The webcast can be accessed at Stryker - Events & Presentations. An archive of the ...

VB Spine is a Strategic Partner to Stryker with Access to Mako Spine and Copilot Marc, John and Anthony Viscogliosi Lead VB ...

The stock's rise snapped a four-day losing streak.

Stryker (NYSE: SYK) announced today that it completed the sale of its U.S. spinal implants business to Viscogliosi Brothers.